Side-by-side comparison of AI visibility scores, market position, and capabilities
Zurich AI wearable camera with computer vision for automatic food nutrition logging; YC W23-backed with $450K revenue and $93K+ DROP preorders for Q4 2025 competing for automated fitness nutrition tracking.
rex.fit is a Zürich-based fitness technology company building The DROP — an AI-powered wearable camera that uses computer vision to automatically log food nutrition by photographing meals, track workouts, and generate gamified fitness challenges for health-conscious consumers who want data-driven fitness without manual calorie logging. Founded in 2023 by Ahmad Roumie and Rangel Milushev and backed by Y Combinator (W23), rex.fit generated $450,000 in revenue with a 2-person team and launched The DROP ($199 USD) with $93,000+ in pre-orders (approximately 450 units) targeted for Q4 2025 shipment, establishing a novel computer-vision food tracking wearable in a category dominated by wrist-based fitness trackers.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.